Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable Bowel Syndrome
10.1053/j.gastro.2016.08.003 · doi-reference
A comprehensive review of the usefulness of prebiotics, probiotics, and postbiotics in the diagnosis and treatment of small intestine bacterial overgrowth
10.3390/microorganisms13010057 · doi-reference
Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence
10.1097/mcg.0000000000000814 · doi-reference
Antibiotic treatment of constipation-predominant irritable bowel syndrome
10.1007/s10620-014-3157-8 · doi-reference
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test
10.1097/mcg.0b013e3181c64c90 · doi-reference
Diet and intestinal bacterial overgrowth: Is there evidence?
10.12998/wjcc.v10.i15.4713 · doi-reference
Rifaximin therapy for patients with irritable bowel syndrome without constipation
10.1056/nejmoa1004409 · doi-reference
Symptomatic response to antibiotics in patients with small intestinal bacterial overgrowth: a systematic review and meta-analysis
10.5056/jnm22187 · doi-reference
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
10.1111/apt.12479 · doi-reference
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
10.1111/apt.13928 · doi-reference
Rifaximin-alpha increases lactase activity in patients with irritable bowel syndrome without constipation and small intestinal bacterial overgrowth
10.1007/s10620-024-08767-1 · doi-reference
Update on the role of rifaximin in digestive diseases
10.15403/jgld-4871 · doi-reference
Small intestinal bacterial overgrowth: current update
10.1097/mog.0000000000000971 · doi-reference
Pattern of methane levels with lactulose breath testing; can we shorten the test duration?
10.1002/jgh3.12592 · doi-reference
What is the optimal threshold for an increase in hydrogen and methane levels with glucose breath test (GBT) for detection of small intestinal bacterial overgrowth (SIBO)?
10.1016/s0016-5085(14)61927-2 · doi-reference
Shedding light on elevated baseline hydrogen and flat-line patterns during breath testing
10.14309/ajg.0000000000000659 · doi-reference
Measurement of hydrogen sulfide during breath testing correlates to patient symptoms
10.1016/s0016-5085(17)30993-9 · doi-reference
Phenotype and antibiotic response in patients with flat line breath test results: a large scale database analysis: 448
10.14309/00000434-201810001-00448 · doi-reference
Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis
10.1016/s0016-5085(15)32494-x · doi-reference
Efficacy and findings of a blinded randomized reintroduction phase for the low FODMAP diet in irritable bowel syndrome
10.1053/j.gastro.2024.02.008 · doi-reference
Understanding the significant interaction between hydrogen and methane in the performance and interpretation of breath testing
10.1016/s0016-5085(15)32493-8 · doi-reference
Carbohydrate-induced gastrointestinal symptoms: development and validation of a test-specific symptom questionnaire for an adult population, the adult Carbohydrate Perception Questionnaire
10.1097/meg.0000000000001880 · doi-reference
Development and validation of the paediatric Carbohydrate Perception Questionnaire (pCPQ), an instrument for the assessment of carbohydrate-induced gastrointestinal symptoms in the paediatric population
10.1111/nmo.13934 · doi-reference
Fermentable sugar ingestion, gas production, and gastrointestinal and central nervous system symptoms in patients with functional disorders
10.1053/j.gastro.2018.07.013 · doi-reference
Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome
10.1053/j.gastro.2016.09.062 · doi-reference
The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS
10.1136/gutjnl-2017-313750 · doi-reference
Diagnostic utility of carbohydrate breath tests for SIBO, fructose, and lactose intolerance
10.1007/s10620-019-05889-9 · doi-reference
The brain-gut axis in abdominal pain syndromes
10.1146/annurev-med-012309-103958 · doi-reference
Delayed analysis of hydrogen-methane breath samples
10.5223/pghn.2022.25.1.13 · doi-reference
Acidic colonic microclimate--possible reason for false negative hydrogen breath tests
10.1136/gut.29.1.21 · doi-reference
Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients
10.1038/sj.ejcn.1601651 · doi-reference
Storage of breath samples for H2 analyses
10.1016/0016-5085(88)90260-0 · doi-reference
Evaluation of lactulose, lactose, and fructose breath testing in clinical practice: a focus on methane
10.1002/jgh3.12240 · doi-reference
The degree of breath methane production in IBS correlates with the severity of constipation
10.1111/j.1572-0241.2007.01072.x · doi-reference
ACG clinical guideline: small intestinal bacterial overgrowth
10.14309/ajg.0000000000000501 · doi-reference
Small intestinal bacterial overgrowth in children: a state-of-the-art review
10.3389/fped.2019.00363 · doi-reference
Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms
10.1007/s10620-007-0022-z · doi-reference
The role of diagnostic testing in irritable bowel syndrome
10.1016/j.gtc.2010.12.001 · doi-reference
Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution
10.1097/mcg.0b013e3181a099a5 · doi-reference
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis
10.1016/j.cgh.2009.06.031 · doi-reference
